Literature DB >> 19394157

Treatment planning to improve delivery accuracy and patient throughput in helical tomotherapy.

David C Westerly1, Emilie Soisson, Quan Chen, Katherine Woch, Leah Schubert, Gustavo Olivera, Thomas R Mackie.   

Abstract

PURPOSE: To investigate delivery quality assurance (DQA) discrepancies observed for a subset of helical tomotherapy patients. METHODS AND MATERIALS: Six tomotherapy patient plans were selected for analysis. Three had passing DQA ion chamber (IC) measurements, whereas 3 had measurements deviating from the expected dose by more than 3.0%. All plans used similar parameters, including: 2.5 cm field-width, 15-s gantry period, and pitch values ranging from 0.143 to 0.215. Preliminary analysis suggested discrepancies were associated with plans having predominantly small leaf open times (LOTs). To test this, patients with failing DQA measurements were replanned using an increased pitch of 0.287. New DQA plans were generated and IC measurements performed. Exit fluence data were also collected during DQA delivery for dose reconstruction purposes.
RESULTS: Sinogram analysis showed increases in mean LOTs ranging from 29.8% to 83.1% for the increased pitch replans. IC measurements for these plans showed a reduction in dose discrepancies, bringing all measurements within +/-3.0%. The replans were also more efficient to deliver, resulting in reduced treatment times. Dose reconstruction results were in excellent agreement with IC measurements, illustrating the impact of leaf-timing inaccuracies on plans having predominantly small LOTs.
CONCLUSIONS: The impact of leaf-timing inaccuracies on plans with small mean LOTs can be considerable. These inaccuracies result from deviations in multileaf collimator latency from the linear approximation used by the treatment planning system and can be important for plans having a 15-s gantry period. The ability to reduce this effect while improving delivery efficiency by increasing the pitch is demonstrated.

Entities:  

Mesh:

Year:  2009        PMID: 19394157      PMCID: PMC2768470          DOI: 10.1016/j.ijrobp.2009.02.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Megavoltage CT on a tomotherapy system.

Authors:  K J Ruchala; G H Olivera; E A Schloesser; T R Mackie
Journal:  Phys Med Biol       Date:  1999-10       Impact factor: 3.609

2.  Tomotherapy.

Authors:  T R Mackie; J Balog; K Ruchala; D Shepard; S Aldridge; E Fitchard; P Reckwerdt; G Olivera; T McNutt; M Mehta
Journal:  Semin Radiat Oncol       Date:  1999-01       Impact factor: 5.934

3.  Clinical helical tomotherapy commissioning dosimetry.

Authors:  John Balog; Gustavo Olivera; Jeff Kapatoes
Journal:  Med Phys       Date:  2003-12       Impact factor: 4.071

4.  A technique for the quantitative evaluation of dose distributions.

Authors:  D A Low; W B Harms; S Mutic; J A Purdy
Journal:  Med Phys       Date:  1998-05       Impact factor: 4.071

5.  An investigation of tomotherapy beam delivery.

Authors:  J N Yang; T R Mackie; P Reckwerdt; J O Deasy; B R Thomadsen
Journal:  Med Phys       Date:  1997-03       Impact factor: 4.071

6.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Authors:  K S Chao; J O Deasy; J Markman; J Haynie; C A Perez; J A Purdy; D A Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

7.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.

Authors:  T R Mackie; T Holmes; S Swerdloff; P Reckwerdt; J O Deasy; J Yang; B Paliwal; T Kinsella
Journal:  Med Phys       Date:  1993 Nov-Dec       Impact factor: 4.071

8.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Authors:  Michael J Zelefsky; Zvi Fuks; Margie Hunt; Yoshiya Yamada; Christine Marion; C Clifton Ling; Howard Amols; E S Venkatraman; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

9.  Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements.

Authors:  Rufus A Scrimger; Wolfgang A Tomé; Gustavo H Olivera; Paul J Reckwerdt; Minesh P Mehta; Jack F Fowler
Journal:  Am J Clin Oncol       Date:  2003-02       Impact factor: 2.339

10.  Quality assurance of a helical tomotherapy machine.

Authors:  J D Fenwick; W A Tomé; H A Jaradat; S K Hui; J A James; J P Balog; C N DeSouza; D B Lucas; G H Olivera; T R Mackie; B R Paliwal
Journal:  Phys Med Biol       Date:  2004-07-07       Impact factor: 3.609

View more
  10 in total

1.  Evaluation of PTW Seven29 for tomotherapy patient-specific quality assurance and comparison with ScandiDos Delta(4).

Authors:  Pamela Myers; Sotirios Stathakis; Alonso N Gutiérrez; Carlos Esquivel; Panayiotis Mavroidis; Niko Papanikolaou
Journal:  J Med Phys       Date:  2012-04

2.  Effects of dose scaling on delivery quality assurance in tomotherapy.

Authors:  Nathan Whitmore; Adrian Nalichowski; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

3.  Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans.

Authors:  Diana Binny; Craig M Lancaster; Selina Harris; Steven R Sylvander
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

4.  On the complexity of helical tomotherapy treatment plans.

Authors:  Tania Santos; Tiago Ventura; Josefina Mateus; Miguel Capela; Maria do Carmo Lopes
Journal:  J Appl Clin Med Phys       Date:  2020-05-04       Impact factor: 2.102

5.  Evaluation and Validation of IBA I'MatriXX Array for Patient-Specific Quality Assurance of TomoTherapy®.

Authors:  N V N Madhusudhana Sresty; A Krishnam Raju; B Nagarjuna Reddy; V C Sahithya; Yakub Mohmd; G Deleep Kumar; T Anil Kumar; Tasneem Rushdi; S Aparna; G Durga Prasad; Harjot Kaur Bajwa
Journal:  J Med Phys       Date:  2019 Jul-Sep

6.  Statistical Analysis of Treatment Planning Parameters for Prediction of Delivery Quality Assurance Failure for Helical Tomotherapy.

Authors:  Kyung Hwan Chang; Young Hyun Lee; Byung Hun Park; Min Cheol Han; Jihun Kim; Hojin Kim; Min-Seok Cho; Hyokyeong Kang; Ho Lee; Dong Wook Kim; Kwangwoo Park; Jaeho Cho; Yong Bae Kim; Jin Sung Kim; Chae-Seon Hong
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Dose delivery accuracy on helical tomotherapy for 4-dimensional tumor motion - a phantom study.

Authors:  Raghavendra Holla; David Khanna; V K Sathiya Narayanan
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09

8.  Teflon cylindrical phantom for delivery quality assurance of stereotactic body radiotherapy (SBRT).

Authors:  Danielle W Lack; Ali Kakakhel; Ross Starin; Michael Snyder
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

9.  Helical tomotherapy: Comparison of Hi-ART and Radixact clinical patient treatments at the Technical University of Munich.

Authors:  K M Kraus; S Kampfer; J J Wilkens; L Schüttrumpf; S E Combs
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

10.  Leaf open time sinogram (LOTS): a novel approach for patient specific quality assurance of total marrow irradiation.

Authors:  Rajesh Thiyagarajan; Dayananda Shamurailatpam Sharma; Suryakant Kaushik; Mayur Sawant; K Ganapathy; N Arunai Nambi Raj; Srinivas Chilukuri; Sham C Sundar; Kartikeswar Ch Patro; Arjunan Manikandan; M P Noufal; Rangasamy Sivaraman; Jose Easow; Rakesh Jalali
Journal:  Radiat Oncol       Date:  2020-10-14       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.